In addition, nucleolin can be a therapeutic target for breast tumors [52] and we showed that the rapamycin was effective in decreasing the expression of this protein, since in the treated group of canine mammary tumor cells cultured in vitro the protein was found in lower abundance. This evidence concerns the gene NUCLEOLIN and breast neoplasm.